English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech Clinical Trials
노보텍, 고객의 기대를 뛰어넘는 성과로 CRO 리더십 상 수상
Jun 24, 2022 21:00 HKT
Novotech Receives CRO Leadership Award for Exceeding Customer Expectations
Jun 23, 2022 08:00 HKT
Novotech 因超出客户期望而获得 CRO 领导奖
Jun 23, 2022 08:00 HKT
Novotech 因超出客戶期望而獲得 CRO 領導獎
Jun 23, 2022 08:00 HKT
노보텍 소속 아시아 태평양 및 미국 지역 임원진, ‘바이오 2022’ 참가
Jun 15, 2022 21:00 HKT
SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development
Jun 15, 2022 08:30 HKT
Novotech 的亚太地区和美国领导团队参加 BIO 2022
Jun 15, 2022 06:00 HKT
Novotech 的亞太地區和美國領導團隊參加 BIO 2022
Jun 15, 2022 06:00 HKT
Novotech's APAC and USA Leadership Teams at BIO 2022
Jun 14, 2022 22:00 HKT
노보텍, 중국 내 종양학 임상 가속화 관련 2022년 엔드포인트 ASCO 전문가 패널 후원
Jun 07, 2022 20:00 HKT
Novotech助力Endpoints ASCO 2022年专家组,加速中国肿瘤临床试验
Jun 07, 2022 08:00 HKT
Novotech助力Endpoints ASCO 2022年專家組,加速中國腫瘤臨床試驗
Jun 07, 2022 08:00 HKT
Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China
Jun 06, 2022 18:00 HKT
노보텍, 초기 단계 종양학 임상 및 미-중 규제 전략에 관한 프리-ASCO 중국 서밋의 전문가 패널들을 후원
Jun 03, 2022 20:00 HKT
Novotech 赞助 ASCO 中国峰会前中美早期肿瘤试验和监管策略专家组
Jun 03, 2022 07:00 HKT
Novotech 贊助 ASCO 中國峰會前中美早期腫瘤試驗和監管策略專家組
Jun 03, 2022 07:00 HKT
Novotech Sponsors Pre-ASCO China Summit Panels on Early Phase Oncology Trials, Regulatory Strategy for China and US
Jun 02, 2022 18:00 HKT
노보텍, 프리-ASCO중국 서밋 후원: 초기 단계 종양학 임상에 기반해 진행 여부 결정
May 12, 2022 21:00 HKT
Elevating Australia's Scientific Acumen: Large Molecule Facility Doubles Size of Australia's Top Bioanalytical Laboratory
May 12, 2022 15:00 HKT
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
May 12, 2022 06:00 HKT
Next >>
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: